Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons
暂无分享,去创建一个
Nathan R. Qi | C. Elias | J. Kopchick | M. Myers | D. Garcia-Galiano | Richard A. Miller | D. Sandoval | M. Garratt | M. Sadagurski | Taylor Landeryou | Gillian Cady
[1] M. Metzger,et al. Distribution of growth hormone-responsive cells in the mouse brain , 2016, Brain Structure and Function.
[2] A. Bartke,et al. Growth hormone modulates hypothalamic inflammation in long‐lived pituitary dwarf mice , 2015, Aging cell.
[3] F. Steyn,et al. Nutrient Sensing Overrides Somatostatin and Growth Hormone‐Releasing Hormone to Control Pulsatile Growth Hormone Release , 2015, Journal of neuroendocrinology.
[4] M. Birnbaum,et al. Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo , 2015, Nature Communications.
[5] B. Lowell,et al. TRAP-seq defines markers for novel populations of hypothalamic and brainstem LepRb neurons , 2015, Molecular metabolism.
[6] M. Schwartz,et al. Control of hepatic glucose metabolism by islet and brain , 2014, Diabetes, obesity & metabolism.
[7] Elizabeth A. Jensen,et al. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. , 2014, Endocrinology.
[8] Ana I. Domingos,et al. Profiling of Glucose-Sensing Neurons Reveals that GHRH Neurons Are Activated by Hypoglycemia. , 2013, Cell metabolism.
[9] W. Freeman,et al. Insulin-like growth factor-1 in CNS and cerebrovascular aging , 2013, Front. Aging Neurosci..
[10] G. Johannsson,et al. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations , 2013, Nature Reviews Endocrinology.
[11] G. Anderson,et al. Neither signal transducer and activator of transcription 3 (STAT3) or STAT5 signaling pathways are required for leptin's effects on fertility in mice. , 2013, Endocrinology.
[12] V. Longo,et al. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. , 2013, Physiological reviews.
[13] Noor Akhter,et al. Ablation of leptin signaling to somatotropes: changes in metabolic factors that cause obesity. , 2012, Endocrinology.
[14] Tasneem S. Ansari,et al. Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice , 2011, Journal of visualized experiments : JoVE.
[15] C. Kahn,et al. Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. , 2011, Endocrinology.
[16] D. Burdakov,et al. Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus. , 2011, Endocrinology.
[17] Robert C. Thompson,et al. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. , 2011, Cell metabolism.
[18] D. Leroith,et al. The Intricate Role of Growth Hormone in Metabolism , 2011, Front. Endocrin..
[19] J. Kopchick,et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. , 2011, Endocrine reviews.
[20] R. Zechner,et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. , 2011, Cell metabolism.
[21] Andrzej Bartke,et al. Growth hormone, insulin and aging: The benefits of endocrine defects , 2011, Experimental Gerontology.
[22] A. Bookout,et al. Characterization of Kiss1 neurons using transgenic mouse models , 2011, Neuroscience.
[23] L. Seoane,et al. The vagus nerve as a regulator of growth hormone secretion , 2011, Regulatory Peptides.
[24] S. Bouret,et al. Large litter rearing enhances leptin sensitivity and protects selectively bred diet-induced obese rats from becoming obese. , 2010, Endocrinology.
[25] Clifford B Saper,et al. Identifying the efferent projections of leptin‐responsive neurons in the dorsomedial hypothalamus using a novel conditional tracing approach , 2010, The Journal of comparative neurology.
[26] K. Rahmouni. Leptin-Induced Sympathetic Nerve Activation: Signaling Mechanisms and Cardiovascular Consequences in Obesity. , 2010, Current hypertension reviews.
[27] D. Leroith,et al. Biological effects of growth hormone on carbohydrate and lipid metabolism. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[28] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[29] M. White,et al. Deletion of Irs 2 Causes Reduced Kidney Size in Mice : Role for Inhibition of GSK 3 β ? , 2010 .
[30] M. White,et al. Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3β? , 2010, BMC Developmental Biology.
[31] M. White,et al. Human IL6 enhances leptin action in mice , 2009, Diabetologia.
[32] A. Means,et al. Faculty Opinions recommendation of The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. , 2009 .
[33] O. Madsen,et al. The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells , 2009, Cell.
[34] G. Leinninger. Location, location, location: the CNS sites of leptin action dictate its regulation of homeostatic and hedonic pathways , 2009, International Journal of Obesity.
[35] J. Kopchick,et al. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes , 2009, Diabetologia.
[36] Niels Møller,et al. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. , 2009, Endocrine reviews.
[37] M. Kearney,et al. Role of IGF-1 in glucose regulation and cardiovascular disease , 2008, Expert review of cardiovascular therapy.
[38] C. Kahn,et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. , 2008, The Journal of clinical investigation.
[39] R. Printz,et al. Central Nervous System Neuropeptide Y Signaling Modulates VLDL Triglyceride Secretion , 2008, Diabetes.
[40] F. Ashcroft,et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. , 2007, Cell metabolism.
[41] C. Magnan,et al. Free fatty acids and insulin resistance , 2007, Current opinion in clinical nutrition and metabolic care.
[42] H. Münzberg,et al. Leptin Receptor Signaling and Action in the Central Nervous System , 2006, Obesity.
[43] E. Kang,et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control , 2006, Clinical endocrinology.
[44] G. Norstedt,et al. Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.
[45] C. Saper,et al. Expression of ghrelin receptor mRNA in the rat and the mouse brain , 2006, The Journal of comparative neurology.
[46] F. Nyberg,et al. Distribution of growth hormone receptor mRNA in the brain stem and spinal cord of the rat , 2005, Neuroscience.
[47] A. Pocai,et al. Central leptin acutely reverses diet-induced hepatic insulin resistance. , 2005, Diabetes.
[48] I. Robinson,et al. Hypothalamic STAT Proteins: Regulation of Somatostatin Neurones by Growth Hormone Via STAT5b , 2005, Journal of neuroendocrinology.
[49] A. Pocai,et al. A brain-liver circuit regulates glucose homeostasis. , 2005, Cell metabolism.
[50] C. Bruder,et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. , 2005, Diabetes.
[51] M. White,et al. Insulin receptor substrate proteins and diabetes , 2004, Archives of pharmacal research.
[52] R. Osamura,et al. Leptin and the Pituitary , 2004, Pituitary.
[53] L. Rossetti,et al. Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.
[54] H. Watanobe,et al. Leptin Regulates Growth Hormone-Releasing Factor, Somatostatin, and α-Melanocyte-Stimulating Hormone But Not Neuropeptide Y Release in Rat Hypothalamus In Vivo: Relation with Growth Hormone Secretion , 2002, The Journal of Neuroscience.
[55] C. Ohlsson,et al. Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice. , 2001, Endocrinology.
[56] J. Herrington,et al. Signaling pathways activated by the growth hormone receptor , 2001, Trends in Endocrinology & Metabolism.
[57] Y. Song,et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients , 2001, International Journal of Obesity.
[58] Richard A. Miller,et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] D. Alessi. Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture , 2001 .
[60] D. Alessi. Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. , 2001, Biochemical Society transactions.
[61] 차봉수. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients , 2001 .
[62] K. Nonogaki,et al. New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.
[63] M. Matsuhisa,et al. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. , 2000, Metabolism: clinical and experimental.
[64] J. Hyde,et al. The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. , 1999, Endocrinology.
[65] M. Nishihara,et al. Obesity and insulin resistance in human growth hormone transgenic rats. , 1998, Endocrinology.
[66] P. Kelly,et al. Growth-hormone-receptor and cytokine-receptor-family signaling. , 1998, European journal of biochemistry.
[67] J. Kamegai,et al. Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. , 1996, Endocrinology.
[68] R. Steiner,et al. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.
[69] J. Ihle. STATs: Signal Transducers and Activators of Transcription , 1996, Cell.
[70] J. de Belleroche,et al. Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic Excitation , 1996, Journal of neurochemistry.
[71] G. Shulman,et al. Local Ventromedial Hypothalamus Glucopenia Triggers Counterregulatory Hormone Release , 1995, Diabetes.
[72] N. Barzilai,et al. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. , 1993, The Journal of biological chemistry.
[73] M. Waters,et al. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. , 1993, Brain research. Developmental brain research.
[74] D. Clemmons,et al. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. , 1988, The Journal of clinical endocrinology and metabolism.
[75] T. Claus,et al. Hormonal regulation of hepatic gluconeogenesis and glycolysis. , 1988, Annual review of biochemistry.
[76] P. Cryer,et al. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.
[77] S. Hojvat,et al. Growth hormone (GH) immunoreactivity in the rodent and primate CNS: Distribution, characterization and presence posthypophysectomy , 1982, Brain Research.
[78] T. Shimazu. Glycogen Synthetase Activity in Liver: Regulation by the Autonomic Nerves , 1967, Science.